We are live on
!
Find out more
TCM
TCG Crossover Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
1,165.83%
This Fund
S&P 500
This Quarter
Est. Return
-8.23%
1 Year Est. Return
+1,165.83%
3 Year Est. Return
+3,168.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$235M
AUM Growth
-$13.7M
(-5.5%)
Cap. Flow
+$21.9M
Cap. Flow
% of AUM
9.32%
Top 10 Holdings %
Top 10 Hldgs %
80.18%
Holding
22
New
2
Increased
4
Reduced
4
Closed
–
Top Buys
| 1 |
Kura Oncology
KURA
|
+$9.51M |
| 2 |
MoonLake Immunotherapeutics
MLTX
|
+$6.29M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$4.99M |
| 4 |
ETNB
89bio
ETNB
|
+$3.42M |
| 5 |
Cogent Biosciences
COGT
|
+$3.41M |
Top Sells
| 1 |
ALPN
Alpine Immune Sciences Inc
ALPN
|
+$3.93M |
| 2 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$1.35M |
| 3 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
+$1.04M |
| 4 |
Tango Therapeutics
TNGX
|
+$498K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cogent Biosciences
COGT
$6.45B
| $31.4M | 13.34% |
3,481,042
+500,000
| +17% | +$3.41M |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $28M | 11.91% |
2,914,250
+397,330
| +16% | +$4.99M |
|
3
Geron
GERN
$905M
| $23.4M | 9.94% |
15,096,342
+810,627
| +6% | +$1.15M |
|
|
4
Kura Oncology
KURA
$960M
| $21.4M | 9.09% |
1,167,642
+661,219
| +131% | +$9.51M |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $17.4M | 7.4% |
5,905,400
| – | – |
|
6
Aclaris Therapeutics
ACRS
$739M
| $16M | 6.79% |
1,144,939
| – | – |
|
7
Viridian Therapeutics
VRDN
$1.97B
| $15.2M | 6.46% |
1,314,000
| – | – |
|
|
KDNY
8
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $13.9M | 5.92% |
796,460
-85,893
| -10% | -$1.35M |
|
|
JBIO
9
Jade Biosciences
JBIO
$1.26B
| $13.9M | 5.91% |
25,416
| – | – |
|
10
Entrada Therapeutics
TRDA
$262M
| $8.08M | 3.43% |
663,694
| – | – |
|
|
MRUS
11
DELISTED
Merus
MRUS
| $6.79M | 2.89% |
300,000
| – | – |
|
12
Tyra Biosciences
TYRA
$1.87B
| $6.41M | 2.72% |
896,418
| – | – |
|
|
AKUS
13
DELISTED
Akouos Inc
AKUS
| $6.33M | 2.69% |
1,350,006
| – | – |
|
|
14
Tango Therapeutics
TNGX
$4.47B
| $5.31M | 2.26% |
1,172,250
-82,250
| -7% | -$498K |
|
|
15
MoonLake Immunotherapeutics
MLTX
$1.59B
| $5.25M | 2.23% |
+1,000,000
| New | +$6.29M |
|
|
ALPN
16
DELISTED
Alpine Immune Sciences Inc
ALPN
| $4.92M | 2.09% |
578,260
-455,962
| -44% | -$3.93M |
|
|
ETNB
17
DELISTED
89bio
ETNB
| $3.65M | 1.55% |
+1,133,196
| New | +$3.42M |
|
18
Zai Lab
ZLAB
$2.33B
| $3.29M | 1.4% |
95,000
| – | – |
|
19
Dianthus Therapeutics
DNTH
$5.13B
| $2.55M | 1.08% |
132,758
| – | – |
|
20
AnaptysBio
ANAB
$1.6B
| $1.19M | 0.5% |
58,515
| – | – |
|
|
ELEV
21
DELISTED
Elevation Oncology
ELEV
| $777K | 0.33% |
555,000
| – | – |
|
|
PRDS
22
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $181K | 0.08% |
59,039
-170,061
| -74% | -$1.04M |
|
Similar funds
DILIC
IIM
KCM
ACM
BCP
AL
ACA
MSC